VANGUARD GROUP INC - PRELUDE THERAPEUTICS INC ownership

PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 62 filers reported holding PRELUDE THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of PRELUDE THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$3,850,253
-20.1%
1,010,565
-0.6%
0.00%
Q1 2024$4,820,576
+12.1%
1,016,999
+1.0%
0.00%
Q4 2023$4,299,275
+42.9%
1,006,856
+3.4%
0.00%
Q3 2023$3,008,442
-29.8%
973,606
+2.2%
0.00%
Q2 2023$4,288,221
-17.9%
952,938
+4.0%
0.00%
Q1 2023$5,221,280
-3.9%
916,014
+1.9%
0.00%
Q4 2022$5,431,856
-8.6%
899,314
+0.0%
0.00%
Q3 2022$5,943,000
+26.6%
899,0450.0%0.00%
Q2 2022$4,693,000
-15.0%
899,045
+12.3%
0.00%
Q1 2022$5,523,000
-42.5%
800,498
+3.8%
0.00%
Q4 2021$9,604,000
-73.0%
771,440
-32.1%
0.00%
-100.0%
Q3 2021$35,522,000
+10.2%
1,136,722
+0.9%
0.00%0.0%
Q2 2021$32,238,000
-14.2%
1,126,047
+29.8%
0.00%0.0%
Q1 2021$37,585,000
-20.4%
867,420
+31.5%
0.00%0.0%
Q4 2020$47,212,000
+3381.7%
659,845
+1366.3%
0.00%
Q3 2020$1,356,00045,0000.00%
Other shareholders
PRELUDE THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Orbimed Advisors 10,039,691$66,362,0001.23%
Baker Brothers Advisors 10,123,824$66,918,0000.44%
HHLR ADVISORS, LTD. 583,333$3,856,0000.10%
CAXTON ASSOCIATES LP 85,992$568,0000.08%
Virtus ETF Advisers LLC 24,180$160,0000.06%
GSA CAPITAL PARTNERS LLP 54,173$358,0000.05%
DENALI ADVISORS LLC 8,200$54,0000.03%
PDT Partners, LLC 12,641$84,0000.01%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 2,402,595$15,881,153,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 36,949$244,0000.01%
View complete list of PRELUDE THERAPEUTICS INC shareholders